Whalegun
Home

Regeneron Pharmaceuticals REGN spent $370K on lobbying in Q2 2023 · Health Issues, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$370,000
Quarter
Q2 2023
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
23/07/20

Down 19.6% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $370K on lobbying in Q2 2023 · Health Issues, Medicare and 1 more issue | Whalegun